Organizations Filed Purposes:
The mission of the Cardiovascular Innovation Institute is to improve lives through world-class cardiovascular research, scientific discovery and new enterprise creation.
THE MISSION OF THE CARDIOVASCULAR INNOVATION INSTITUTE IS TO IMPROVE LIVES THROUGH WORLD-CLASS CARDIOVASCULAR RESEARCH, SCIENTIFIC DISCOVERY AND NEW ENTERPRISE CREATION.
Research in the Cardiovascular Innovation Institute (CII) is focused on studying how the heart and cardiovascular system functions both normally and in the diseased state. The CII is doing research on the cellular and molecular level developing new knowledge on the underlining cause of cardiovascular disease. One of our researchers is studying small vessel disease in the hearts of women. This research is leading to new therapies for the treatment of women who have myocardial infarctions. Along with this research, work is being performed with adult stem cells turning the these cells into capillary to be vascularized ischemic myocardium. This work has been recognized by the National Institutes of Health and resulted in a R01 grant. Other researchers in the CII are working with C - RNA to detect both heart and lung disease and to better understand the mechanisms of action to help improve clinical treatments. There is also a very large lung research program at the Institute which is exploring mechanisms causing inflammatory lung disease using ex vivo lung perfusion techniques. One of the largest programs is the continual development of new ventricular assist devices and total artificial hearts. We have an outstanding large animal research lab and work in collaboration with multiple companies and the FDA perfecting the new devices for clinical testing. Researchers at the CII have published over 27 peer-reviewed articles during the year.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Roberto Bolli Md | Scientific Director (to 12/31/18) | 0.5 | $0 |
| Laman Gray Md | Medical and Exec. Director | 0.5 | $0 |
| William A Stone | Director | 0.5 | $0 |
| Richard A Schultz | Director | 0.5 | $0 |
| Jacquelyne Richardson | Director | 0.5 | $0 |
| Jeff Polson | Director | 0.5 | $0 |
| John Mccall | Director | 0.5 | $0 |
| David Laird | Director | 0.5 | $0 |
| Sandra Hammond | Director | 0.5 | $0 |
| Toni Ganzel Md | Director | 0.5 | $0 |
| Daniel A Durbin | Director | 0.5 | $0 |
| Louis Waterman | Vice Chair | 0.5 | $0 |
| Gregory C Postel Md | Chair (to 11/13/2018) | 0.5 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202001979349301810_public.xml